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Prediabetes and type 2 diabetes (T2D) are associated with microvascular dysfunction (1) , which may explain their increased risk of microvascular complications. However, mechanisms remain poorly understood. We investigated to what extent prediabetes-and T2D-associated microvascular dysfunction is potentially attributable to (composite indices of) hyperglycemia, insulin resistance, blood pressure, arterial stiffness, lipid profile, and/or low-grade inflammation.
In the Maastricht Study (2), a T2D-enriched population-based cohort study (n 5 1,791, 49% women, aged 60 6 8 years), we determined flicker lightinduced retinal arteriolar %-dilation (1) using the Dynamic Vessel Analyzer, heat-induced skin %-hyperemia (1) using laser Doppler flowmetry, and diabetes status using the oral glucose tolerance test ( Qualitatively similar patterns of mediation were found in additional analyses (available on request) in which we additionally adjusted for smoking, BMI, and (micro)vascular complications, used absolute retinal arteriolar diameter and skin blood flow as outcomes, investigated arterial stiffness as a potential mediator, or used a composite index of long-term hyperglycemic measures (glycated hemoglobin A 1c and skin autofluorescence).
These findings suggest that hyperglycemia itself, rather than the cardiovascular risk context associated with prediabetes and T2D, is the main contributor to both prediabetes-and T2D-associated retinal and skin microvascular dysfunction. This supports an early detrimental effect of hyperglycemia on the retinal and skin microvascular responses. Impairments in both these responses reflect decreased availability of nitric oxide and are likely a reflection of microvascular endothelial dysfunction, possibly in conjunction with neuronal dysfunction (3, 4) .
Our study had some limitations. First, data were cross-sectional; therefore, we cannot exclude reverse causality. Second, inflammatory markers drawn from venous plasma, compared with local Markers of lipid profile Total-to-HDL cholesterol ratio 3.5 6 1.1 3.9 6 1. Baseline skin blood flow (PU)| 10.8 6 6.4 11.7 6 7.2 11.0 6 5.7
Skin hyperemic response (%)| We conclude that hyperglycemia is the main contributor to prediabetes-and T2D-associated retinal and skin microvascular dysfunction. Longitudinal studies should assess whether hyperglycemia, via retinal and skin microvascular (endothelial) dysfunction, contributes to the development of microvascular complications in prediabetes and T2D.
